基于PET/CT的深度学习特征与代谢肿瘤体积构建非小细胞肺癌风险分层
研究纳入590例非小细胞肺癌患者(训练集413例、测试集177例),利用卷积神经网络提取PET/CT深度学习特征并结合全身代谢肿瘤体积(MTVwb)构建联合风险分层(CRS),评估其对总生存期(OS)和无进展生存期(PFS)的预测价值。结果显示CRS是OS和PFS的独立预测因子,其C-index在多数情况下显著高于TNM分期,CRS联合TNM分期的列线图模型表现最优(训练集C-index=0.741,测试集=0.771)。
要点
- CRS由PET/CT深度学习特征和MTVwb构建,是OS和PFS的独立预测因子。
- CRS的C-index较TNM分期有统计学显著提升,但测试集预测OS时除外(0.73 vs 0.736)。
- CRS联合TNM分期的列线图在训练集和测试集均表现最优(C-index=0.741和0.771)。
核心结论
- 加入CRS可提升TNM分期的预测能力,并显示出作为辅助医生制定治疗决策的有用工具的潜力。
研究设计与样本
- 研究纳入590例非小细胞肺癌患者,训练集413例、测试集177例;采用卷积神经网络提取PET/CT深度学习特征,结合全身代谢肿瘤体积(MTVwb)构建联合风险分层(CRS),并与TNM分期进行对比和整合,在测试集中验证。
诊断标准与关键数值
- CRS对OS的C-index:训练集0.71 vs TNM分期0.691,测试集0.73 vs TNM分期0.736。
- CRS对PFS的C-index:训练集0.702 vs TNM分期0.686,测试集0.732 vs TNM分期0.71。
- CRS联合TNM分期的列线图C-index:训练集0.741,测试集0.771。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To build a risk stratification by incorporating PET/CT-based deep learning features and whole-body metabolic tumor volume (MTVwb), which was to make predictions about overall survival (OS) and progression-free survival (PFS) for those with non-small cell lung cancer (NSCLC) as a complement to the TNM staging.
MATERIALS AND METHODS: The study enrolled 590 patients with NSCLC (413 for training and 177 for testing). Features were extracted by employing a convolutional neural network. The combined risk stratification (CRS) was constructed by the selected features and MTVwb, which were contrasted and integrated with TNM staging. In the testing set, those were verified.
RESULTS: Multivariate analysis revealed that CRS was an independent predictor of OS and PFS. C-indexes of the CRS demonstrated statistically significant increases in comparison to TNM staging, excepting predicting OS in the testing set (for OS, C-index=0.71 vs. 0.691 in the training set and 0.73 vs. 0.736 in the testing set; for PFS, C-index=0.702 vs. 0.686 in the training set and 0.732 vs. 0.71 in the testing set). The nomogram that combined CRS with TNM staging demonstrated the most superior model performance in the training and testing sets (C-index=0.741 and 0.771).
CONCLUSION: The addition of CRS improves TNM staging's predictive power and shows potential as a useful tool to support physicians in making treatment decisions.
引用
- Ju L, Li W, Zuo R, et al. Deep Learning Features and Metabolic Tumor Volume Based on PET/CT to Construct Risk Stratification in Non-small Cell Lung Cancer. Acad Radiol. 2024. PMID: 38740530. doi:10.1016/j.acra.2024.04.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。